The field of diabetes treatment continues to experience a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. These https://brendaooxr378717.uzblog.net/upcoming-glp-1-receptor-agonists-retatrutide-and-trizepatide-52578474